Consistent with previous reports (37, 38), the removal of CD8+ T cells markedly improved GVHD symptoms and liver damage in hPBMC mice, indicating that these symptoms in hPBMC mice are CD8+ T cell dependent (Figure 1, B and C). The gene discussed is CD8A; the disease is graft versus host disease.